SHMT2 and neoplasm: Ectopic over-expression of SHTM2 in xenograft tumors was associated with a significant increase in tumor volume (Fig 5A), whereas we did not measure a significant change in tumor growth after SHMT2 knockdown (Fig 5A, compare lanes 1 and 3).